MedTrace Logo

The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery

NCT02782429 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-05-25

No results posted yet for this study

Summary

The purpose of this study is to analyze the Ketamine with its anti-inflammatory profile would be able to prevent cognitive disorders in the postoperative period of cardiac surgery, since these disorders contribute to an impact on morbidity / mortality in this population.

Conditions

Interventions

DRUG

Ketamine

OTHER

Saline

Sponsors & Collaborators

  • Rebeca Gonelli Albanez da Cunha Andrade

    collaborator UNKNOWN

  • Flavia orange

    lead OTHER

Principal Investigators

  • Rebeca GA Andrade, master · Instituto de Medicina Integral Prof Fernando Figueira

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782429 on ClinicalTrials.gov